2026年生物科技專業(yè)英語模擬練習(xí)題Part1:ReadingComprehension(閱讀理解)共5題，每題2分，總分10分Instructions:Readthepassagebelowandchoosethebestanswerforeachquestion.Passage:ThebiotechnologyindustryhasseensignificantadvancementsinCRISPR-Cas9gene-editingtechnologyoverthepastdecade.CompanieslikeCRISPRTherapeuticsandEditasMedicinehavebeenleadingthechargeindevelopinggenetherapiesforgeneticdisorders.However,challengesremainintermsofdeliveryefficiencyandoff-targeteffects.Recentstudiessuggestthatlipidnanoparticles(LNPs)mayimprovedelivery,butregulatoryhurdlesintheU.S.andEuroperemainabottleneck.China,ontheotherhand,hasbeeninvestingheavilyinbiotechR&D,withcompanieslikeBGIandZoomedicinemakingstridesinsyntheticbiology.Despitetheseefforts,ethicalconcernspersist,particularlyregardinggermlineediting.TheWorldHealthOrganization(WHO)hascalledforstricterguidelinestoensureresponsibleinnovation.Questions:1.WhatistheprimaryfocusofCRISPRTherapeuticsandEditasMedicine?A)DevelopingmRNAvaccinesB)GenetherapyforgeneticdisordersC)ProducingbiofuelsD)Enhancingagriculturalyields2.WhattechnologyisbeingexploredtoimproveCRISPRdelivery?A)ViralvectorsB)LipidnanoparticlesC)CRISPR-Cas12D)mRNAdeliverysystems3.WhichregionisinvestingmostheavilyinbiotechR&D?A)UnitedStatesB)EuropeC)ChinaD)Japan4.Whatisamajorethicalconcernregardinggeneediting?A)HighcostsoftherapyB)RegulatoryapprovaldelaysC)GermlineeditingD)Limitedpatientaccess5.WhatdoestheWorldHealthOrganization(WHO)recommendregardinggeneediting?A)CompletebanongenetherapyB)EncouragementofrapidcommercializationC)StricterguidelinesforresponsibleinnovationD)ReducedfundingforR&DPart2:VocabularyinContext(詞匯運(yùn)用)共5題，每題2分，總分10分Instructions:Fillintheblankswiththemostappropriatewordfromthelistbelow.|Words:|innovative|efficacy|mitigate|biosafety|proprietary|regenerative||-|--|||-||-|1.Thenewdrugdemonstratedhigh______intreatingcancerpatients.2.Researchersareworkingon______techniquestorepairdamagedtissues.3.Thecompany’s______technologyisprotectedbypatents.4.Proper______protocolsareessentialtopreventlabcontamination.5.Thestudyaimedto______therisksofsideeffects.Part3:SentenceTransformation(句子改寫)共5題，每題2分，總分10分Instructions:Rewritethefollowingsentencesinthepassivevoice.1.Scientistsdiscoveredanewenzymethatbreaksdownplastic.2.TheFDAapprovedthegenetherapyforclinicaltrials.3.Researchersaretestingthevaccineonanimalmodels.4.Investorsprovidedfundingforthestartup.5.Theteampublishedthefindingsinaleadingjournal.Part4:SummaryWriting(摘要寫作)共1題，10分Instructions:Readthepassagebelowandwritea100-wordsummaryinyourownwords.Passage:TheCOVID-19pandemicacceleratedtheadoptionofmRNAtechnologyinbiotech.CompanieslikePfizer-BioNTechandModernaleveragedmRNAplatformstodeveloprapidvaccines.However,challengesremainintermsoflong-termstorageandscalability.Researchersareexploringnoveladjuvantsanddeliverysystemstoenhancevaccineefficacy.Meanwhile,inemergingmarketslikeIndiaandBrazil,vaccinedistributionhasbeenhamperedbylogisticalissues.TheWHOhasemphasizedtheneedforglobalcollaborationtoensureequitableaccess.AdvancesinmRNAtechnologymayalsorevolutionizecancerimmunotherapy,butclinicaltrialsarestillinearlystages.Part5:Translation(翻譯)共5題，每題2分，總分10分Instructions:TranslatethefollowingsentencesintoEnglish.1.中國生物技術(shù)公司正在開發(fā)針對阿爾茨海默病的基因療法。2.脂質(zhì)納米顆?？梢蕴岣呋蚓庉嫻ぞ叩倪f送效率。3.歐洲藥品管理局（EMA）對新型生物制劑的審批流程非常嚴(yán)格。4.基因編輯技術(shù)的進(jìn)步引發(fā)了廣泛的倫理爭議。5.許多國家正在制定新的生物安全法規(guī)以應(yīng)對新興傳染病。AnswerKeyandExplanationPart1:ReadingComprehension1.B)GenetherapyforgeneticdisordersExplanation:ThepassagementionsCRISPRTherapeuticsandEditasMedicineasleadersingenetherapyforgeneticdisorders.2.B)LipidnanoparticlesExplanation:ThepassagestatesthatLNPsmayimproveCRISPRdeliveryefficiency.3.C)ChinaExplanation:ThepassagehighlightsChina’sheavyinvestmentinbiotechR&DwithcompanieslikeBGIandZoomedicine.4.C)GermlineeditingExplanation:Thepassagementionsethicalconcernsaboutgermlineediting,supportedbyWHOguidelines.5.C)StricterguidelinesforresponsibleinnovationExplanation:TheWHOiscalledoutforadvocatingstricterguidelinestoensureresponsiblegeneediting.Part2:VocabularyinContext1.efficacyExplanation:"Highefficacy"meansthedrugworkseffectively.2.regenerativeExplanation:"Regenerativetechniques"referstomethodsthatrepairtissues.3.proprietaryExplanation:"Proprietarytechnology"indicatespatented,exclusivetechnology.4.biosafetyExplanation:"Biosafetyprotocols"aremeasurestopreventcontamination.5.mitigateExplanation:"Mitigaterisks"meanstoreduceorlessenthem.Part3:SentenceTransformation1.Anewenzymewasdiscoveredbyscientiststhatbreaksdownplastic.2.ThegenetherapywasapprovedbytheFDAforclinicaltrials.3.Animalmodelsweretestedbyresearchersonthevaccine.4.Fundingwasprovidedbyinvestorsforthestartup.5.Thefindingswerepublishedbytheteaminaleadingjournal.Part4:SummaryWritingSummary:TheCOVID-19pandemicspurredmRNAtechnology’suseinbiotech,withPfizer-BioNTechandModernaleadingvaccinedevelopment.Challengeslikestorageandscalabilitypersist,promptingresearchintoadjuvantsanddeliverysystems.Indevelopingnations,logisticalissueshindervaccinedistribution,